CD96 and breast cancer: We next compared expression differences of CD96 mRNA in cancers and normal tissues using Oncomine database, and found it expressed at relatively higher levels in brain cancer, breast cancer, renal cancer, and leukemia than in normal tissues (Figure 2A).